Blepharitis Treatment: Effects, Benefits & What to Expect

Blepharitis (chronic eyelid margin inflammation) is managed, not cured. Treatment targets biofilm, meibomian gland dysfunction (MGD), and inflammation.

Standard Regimen (Daily, Chronic)

  1. Warm compresses: 5–10 min, 40–45°C (mask or washcloth) – liquefies meibum.
  2. Lid hygiene: Gentle scrub with diluted baby shampoo, commercial pads (hypochlorous acid, tea tree oil), or microblepharoexfoliation (BlephEx).
  3. Massage: Express meibomian glands (vertical strokes) after heat.
  4. Artificial tears: Preservative-free, lipid-based for evaporative dry eye.

Pharmacologic Add-Ons

  • Topical azithromycin 1% or doxycycline 40 mg MR (anti-inflammatory, not antimicrobial dose) – for MGD/rosacea.
  • Topical corticosteroids: Short pulse (loteprednol, fluorometholone) for acute flares – monitor IOP.
  • Topical cyclosporine / lifitegrast: For associated aqueous deficiency.
  • Oral omega-3 (re-esterified TG form): 2–3 g EPA/DHA – improves meibum quality.

Expected Benefits

  • ↓ Redness, swelling, crusting, itching, burning, foreign body sensation.
  • ↑ Tear film stability (TBUT), meibum quality.
  • ↓ Corneal staining, ulcer risk.
  • ↑ Visual clarity (stable tear film).
  • ↓ Stye/chalazion recurrence.

Timeline

  • Symptom relief: 2–4 weeks.
  • Sign improvement: 6–12 weeks.
  • Maintenance lifelong – relapse if stopped.

Consistency is key. Ophthalmologist/optometrist guides stepwise escalation.

Illness - Related Articles